Key Points
- Director Emily Rollins sold 1,000 shares of Xometry on April 1 at an average price of $42.02 under a pre-arranged Rule 10b5-1 plan, cutting her stake by about 6.2% to 15,136 shares (≈$636,015).
- Xometry beat the quarter with EPS of $0.16 (vs. $0.12 est.) and revenue of $192.4M (up 29.5% year-over-year), but remains unprofitable with negative margins and a projected -0.66 EPS for the year; analysts are split with an average rating of "Hold" and a $62 average price target.
Xometry, Inc. (NASDAQ:XMTR - Get Free Report) Director Emily Rollins sold 1,000 shares of Xometry stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $42.02, for a total value of $42,020.00. Following the transaction, the director owned 15,136 shares in the company, valued at approximately $636,014.72. This trade represents a 6.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Xometry Stock Performance
Shares of Xometry stock opened at $42.35 on Friday. The business has a fifty day simple moving average of $49.35 and a 200-day simple moving average of $54.65. Xometry, Inc. has a fifty-two week low of $18.59 and a fifty-two week high of $73.87. The firm has a market cap of $2.19 billion, a price-to-earnings ratio of -34.71 and a beta of 0.88. The company has a quick ratio of 3.72, a current ratio of 3.76 and a debt-to-equity ratio of 1.18.
Xometry (NASDAQ:XMTR - Get Free Report) last released its earnings results on Tuesday, February 24th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.12 by $0.04. Xometry had a negative return on equity of 5.49% and a negative net margin of 8.99%.The firm had revenue of $192.40 million for the quarter, compared to analyst estimates of $183.37 million. During the same period in the previous year, the company earned $0.06 earnings per share. Xometry's revenue was up 29.5% compared to the same quarter last year. On average, equities analysts forecast that Xometry, Inc. will post -0.66 EPS for the current fiscal year.
Institutional Trading of Xometry
Hedge funds have recently bought and sold shares of the company. Fuller & Thaler Asset Management Inc. purchased a new position in shares of Xometry in the fourth quarter worth approximately $76,393,000. Ameriprise Financial Inc. lifted its position in shares of Xometry by 54.2% in the 3rd quarter. Ameriprise Financial Inc. now owns 1,964,909 shares of the company's stock valued at $107,029,000 after acquiring an additional 690,558 shares in the last quarter. Durable Capital Partners LP purchased a new stake in shares of Xometry in the 3rd quarter valued at approximately $36,455,000. Gilder Gagnon Howe & Co. LLC boosted its stake in Xometry by 248.8% in the 2nd quarter. Gilder Gagnon Howe & Co. LLC now owns 859,808 shares of the company's stock worth $29,053,000 after purchasing an additional 613,282 shares during the period. Finally, Stephens Investment Management Group LLC boosted its stake in Xometry by 115.2% in the 4th quarter. Stephens Investment Management Group LLC now owns 842,987 shares of the company's stock worth $50,132,000 after purchasing an additional 451,259 shares during the period. 97.31% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on the stock. Weiss Ratings reiterated a "sell (e+)" rating on shares of Xometry in a report on Wednesday, January 21st. Zacks Research upgraded shares of Xometry from a "strong sell" rating to a "hold" rating in a report on Monday, March 2nd. William Blair restated an "outperform" rating on shares of Xometry in a research report on Tuesday, February 24th. Citigroup dropped their price target on Xometry from $75.00 to $65.00 and set a "buy" rating on the stock in a report on Wednesday, February 25th. Finally, UBS Group increased their price objective on Xometry from $54.00 to $55.00 and gave the company a "neutral" rating in a research report on Wednesday, February 25th. Five investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $62.00.
Read Our Latest Report on Xometry
Xometry Company Profile
(
Get Free Report)
Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.
Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
